Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without
Benjamin A Derman1, Jennifer Cooperrider1, Anna Pula1,2
1University of Chicago Chicago Illinois USA.
Hemasphere
|August 21, 2025
Abstract
No abstract available in PubMed .
More Related Videos
07:53Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
4.3K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.1K
